« Back
Home /
Anti-CD22 (pinatuzumab biosimilar) mAb

Anti-CD22 (pinatuzumab biosimilar) mAb

Item no.	DIM-BME100029-100ug
Manufacturer	DIMA Biotechnology
Amount	100 ug
Quantity options	100 uL 100 ug 50 uL 50 ug
Category	Oncology Neuroscience Neural Lineage Markers Antibodies By Cell Type Carcinoma Hematology Leukemia Lymphoma Cell Biology Cell Movement Cell Adhesion Flow Cytometry ELISA Primary Antibodies Progenitor Markers
Type	Antibody Monoclonal
Format	Lyophilized
Applications	FC, ELISA
Specific against	Human (Homo sapiens)
Host	Humanized
Isotype	IgG1 Kappa
Conjugate/Tag	Unconjugated
ECLASS 10.1	42030590
ECLASS 11.0	42030590
UNSPSC	12352203
Alias	CD22,SIGLEC2,BL-CAM,SIGLEC-2,Siglec2,SIGLEC2FLJ22814,ACD22-VCMMAE,DCDT2980S,FCU2803,RG-7593,RO5541072-000,Unconjugated mAb
Similar products	ACD22-VCMMAE, DCDT2980S, FCU2803, RG-7593, RO5541072-000
Shipping Condition	Room temperature
Available
Manufacturer - Category	Biosimilar reference antibodies
Manufacturer - Isotype	Human IgG1 - kappa
Manufacturer - Targets	CD22
Manufacturer - Host	Humanized
Buffer	50% Glycerol; PBS, pH 7.4; 0.1% BSA
Clonality	Monoclonal
Purification	Purified from cell culture supernatant by affinity chromatography
Recommended Dilutions	ELISA 1:5000-10000; Flow Cyt 1:100
Storage	Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
Background	Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. Our unconjugated biosimilar monoclonal antibodies (mAbs) are based on the sequences outlined in relevant patents or scientific publications. These antibodies are in their native, unconjugated form, meaning they do not contain any payload or therapeutic agent attached. They are designed for use in research and development, and their performance has been tested as standalone molecules through comprehensive QC tests.
Description	Anti-CD22 (pinatuzumab biosimilar) mAb
Preservative	0.1% Procline 300
Reconstitution	Reconstitute with deionized water
Formulation & Reconstitution	Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
Guarantee	12 months from date of despatch
Usage	Research use only
Disclaimer	All DIMA recombinant antibodies are genuinely generated by DIMA Biotech. They are all under patent application. Any protein sequencing or reverse engineering attempt is prohibited. We are actively scrutinizing all patent application to ensure no IP infringement.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 ug

available

Delivery expected until 9/4/2025

Express Delivery: Save 6 days

Compare

Add to wishlist

Get an offer